I en række in vitro- interaktionsforsøg (i 4, 5% humant serumalbumin og humant plasma), udviste gadofosveset imidlertid ingen uønsket interaktion med digitoxin, propranolol, verapamil, warfarin, phenprocoumon, ibuprofen, diazepam, ketoprofen, naproxen, diclofenac og piroxicam ved klinisk relevante koncentrationer.
However, in a series of in vitro drug interaction studies (in 4.5% human serum albumin and human plasma), gadofosveset demonstrated no adverse interaction with digitoxin, propranolol, verapamil, warfarin, phenprocoumon, ibuprofen, diazepam, ketoprofen, naproxen, diclofenac and piroxicam at clinically relevant concentrations.